Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026)
Oramed Pharmaceuticals (ORMP) reported Dividends payables of $303000.0 for Q1 2026, up 10.18% quarter-over-quarter from $275000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Dividends payables for 2 years, with the latest figure at $303000.0 in Q1 2026.
- For the quarter ending Q1 2026, Dividends payables changed N/A year-over-year to $303000.0; the trailing twelve-month figure through Mar 2026 stood at $303000.0 (changed N/A YoY), and the FY2025 full-year result was $275000.0, changed N/A from the prior year.
- Dividends payables for Q1 2026 stood at $303000.0, up from $275000.0 in the prior quarter.
- The five-year high for Dividends payables was $303000.0 in Q1 2026, with the low at $275000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | 303,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 303,000.00 |
| Dec 31, 2025 | 275,000.00 |